NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,906 | +18.4% | 3,985 | -6.0% | 0.02% | +125.0% |
| Q2 2023 | $342,738 | +81.4% | 4,238 | +36.4% | 0.01% | 0.0% |
| Q1 2023 | $188,966 | +44362.6% | 3,106 | -54.3% | 0.01% | -27.3% |
| Q4 2022 | $425 | -99.9% | 6,792 | -12.2% | 0.01% | -15.4% |
| Q3 2022 | $484,000 | -0.8% | 7,733 | -1.0% | 0.01% | -13.3% |
| Q2 2022 | $488,000 | -28.0% | 7,810 | -28.5% | 0.02% | +87.5% |
| Q1 2022 | $678,000 | +196.1% | 10,920 | +322.4% | 0.01% | +100.0% |
| Q4 2021 | $229,000 | -3.0% | 2,585 | -10.6% | 0.00% | -20.0% |
| Q3 2021 | $236,000 | +65.0% | 2,892 | +84.7% | 0.01% | +66.7% |
| Q2 2021 | $143,000 | +19.2% | 1,566 | +14.3% | 0.00% | +50.0% |
| Q1 2021 | $120,000 | -4.0% | 1,370 | +3.6% | 0.00% | -60.0% |
| Q4 2020 | $125,000 | -10.1% | 1,323 | -16.4% | 0.01% | -37.5% |
| Q3 2020 | $139,000 | -14.7% | 1,583 | -14.8% | 0.01% | -38.5% |
| Q2 2020 | $163,000 | -8.9% | 1,857 | -17.1% | 0.01% | -27.8% |
| Q1 2020 | $179,000 | -48.6% | 2,241 | -38.8% | 0.02% | -30.8% |
| Q4 2019 | $348,000 | +6.4% | 3,659 | -2.8% | 0.03% | +18.2% |
| Q3 2019 | $327,000 | +85.8% | 3,766 | +110.5% | 0.02% | -8.3% |
| Q1 2019 | $176,000 | -82.0% | 1,789 | -84.4% | 0.02% | -59.3% |
| Q4 2018 | $976,000 | +3.3% | 11,448 | +4.3% | 0.06% | +51.3% |
| Q3 2018 | $945,000 | +78.6% | 10,971 | +56.8% | 0.04% | +77.3% |
| Q2 2018 | $529,000 | -26.8% | 6,999 | -18.7% | 0.02% | -33.3% |
| Q1 2018 | $723,000 | 0.0% | 8,609 | 0.0% | 0.03% | 0.0% |
| Q4 2017 | $723,000 | -31.3% | 8,609 | -29.8% | 0.03% | -21.4% |
| Q3 2017 | $1,052,000 | +5.5% | 12,259 | +2.6% | 0.04% | 0.0% |
| Q2 2017 | $997,000 | +11.8% | 11,943 | -0.6% | 0.04% | +7.7% |
| Q1 2017 | $892,000 | +2.9% | 12,017 | +1.0% | 0.04% | -7.1% |
| Q4 2016 | $867,000 | +65.8% | 11,898 | +79.7% | 0.04% | +55.6% |
| Q3 2016 | $523,000 | -4.6% | 6,620 | -0.3% | 0.03% | -12.9% |
| Q2 2016 | $548,000 | +211.4% | 6,641 | +271.2% | 0.03% | +29.2% |
| Q1 2016 | $176,000 | -68.2% | 1,789 | -72.2% | 0.02% | -35.1% |
| Q4 2015 | $553,000 | – | 6,426 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |